Tripp Leavitt

Tripp Leavitt

Auto-generated profile, based on publicly available information

Tripp Leavitt

Stanford University School of Medicine

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Cell Reports
Verified
Journal Article
Open access
LLLing Liu
Ling Liu
TCTom H. Cheung
Tom H. Cheung
GCGregory W. Charville
Gregory W. Charville
BHBernadette Marie Ceniza Hurgo
Bernadette Marie Ceniza Hurgo
TLTripp Leavitt
Tripp Leavitt
Thomas RandoThomas Rando
Thomas Rando
The ability to maintain quiescence is critical for the long-term maintenance of a functional stem cell pool. To date, the epigenetic and transcriptional characteristics of quiescent stem cells and how they change with age remain largely unknown. In this study, we explore the chromatin features of adult skeletal muscle stem cells, or satellite cells (SCs), which reside predominantly in a quiescent state in fully developed limb muscles of both young and aged mice. Using a ChIP-seq approach to obtain global epigenetic profiles of quiescent SCs (QSCs), we show that QSCs possess a permissive chromatin state in which few genes are epigenetically repressed by Polycomb group (PcG)-mediated histone 3 lysine 27 trimethylation (H3K27me3), and a large number of genes encoding regulators that specify nonmyogenic lineages are demarcated by bivalent domains at their transcription start sites (TSSs). By comparing epigenetic profiles of QSCs from young and old mice, we also provide direct evidence that, with age, epigenetic changes accumulate and may lead to a functional decline in quiescent stem cells. These findings highlight the importance of chromatin mapping in understanding unique features of stem cell identity and stem cell aging.

1 September 2018 in Cell
Verified
Journal Article
Closed access
CCCharles KF Chan
Charles KF Chan
GGGunsagar S. Gulati
Gunsagar S. Gulati
RSRahul Sinha
Rahul Sinha
JTJustin Vincent Tompkins
Justin Vincent Tompkins
MLMichael Lopez
Michael Lopez
Michael T. LongakerMichael T. Longaker
Michael T. Longaker

1 July 2014 in Current Problems in Surgery
Verified
Journal Article
Open access
CHChenyu Huang
Chenyu Huang
TLTripp Leavitt
Tripp Leavitt
LBLauren R. Bayer
Lauren R. Bayer
DODennis P. Orgill
Dennis P. Orgill
The efficacy of NPWT in promoting wound healing has been largely accepted by clinicians, yet the number of high-level clinical studies demonstrating its effectiveness is small and much more can be learned about the mechanisms of action. In the future, hopefully we will have the data to assist clinicians in selecting optimal parameters for specific wounds including interface material, waveform of suction application, and the amount of suction to be applied. Further investigation into specific interface coatings and instillation therapy are also needed. We believe that advances in mechanobiology, the science of wound healing, the understanding of biofilms, and advances in cell therapy will lead to better care for our patients.

1 February 2018 in Advances in Wound Care
Verified
Journal Article
Open access
CMClement D. Marshall
Clement D. Marshall
MHMichael S. Hu
Michael S. Hu
TLTripp Leavitt
Tripp Leavitt
LBLeandra A. Barnes
Leandra A. Barnes
HLH. Peter Lorenz
H. Peter Lorenz
Michael T. LongakerMichael T. Longaker
Michael T. Longaker
Significance: Scarring of the skin from burns, surgery, and injury constitutes a major burden on the healthcare system. Patients affected by major scars, particularly children, suffer from long-term functional and psychological problems. Recent Advances: Scarring in humans is the end result of the wound healing process, which has evolved to rapidly repair injuries. Wound healing and scar formation are well described on the cellular and molecular levels, but truly effective molecular or cell-based antiscarring treatments still do not exist. Recent discoveries have clarified the role of skin stem cells and fibroblasts in the regeneration of injuries and formation of scar. Critical Issues: It will be important to show that new advances in the stem cell and fibroblast biology of scarring can be translated into therapies that prevent and reduce scarring in humans without major side effects. Future Directions: Novel therapies involving the use of purified human cells as well as agents that target specific cells and modulate the immune response to injury are currently undergoing testing. In the basic science realm, researchers continue to refine our understanding of the role that particular cell types play in the development of scar.

1 February 2018 in Advances in Wound Care
Verified
Journal Article
Closed access
LBLeandra A. Barnes
Leandra A. Barnes
CMClement D. Marshall
Clement D. Marshall
TLTripp Leavitt
Tripp Leavitt
MHMichael S. Hu
Michael S. Hu
AMAlessandra L. Moore
Alessandra L. Moore
GGGeoffrey C. Gurtner
Geoffrey C. Gurtner
Significance: Excessive scarring is major clinical and financial burden in the United States. Improved therapies are necessary to reduce scarring, especially in patients affected by hypertrophic and keloid scars. Recent Advances: Advances in our understanding of mechanical forces in the wound environment enable us to target mechanical forces to minimize scar formation. Fetal wounds experience much lower resting stress when compared with adult wounds, and they heal without scars. Therapies that modulate mechanical forces in the wound environment are able to reduce scar size. Critical Issues: Increased mechanical stresses in the wound environment induce hypertrophic scarring via activation of mechanotransduction pathways. Mechanical stimulation modulates integrin, Wingless-type, protein kinase B, and focal adhesion kinase, resulting in cell proliferation and, ultimately, fibrosis. Therefore, the development of therapies that reduce mechanical forces in the wound environment would decrease the risk of developing excessive scars. Future Directions: The development of novel mechanotherapies is necessary to minimize scar formation and advance adult wound healing toward the scarless ideal. Mechanotransduction pathways are potential targets to reduce excessive scar formation, and thus, continued studies on therapies that utilize mechanical offloading and mechanomodulation are needed.

2 June 2016 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
TLTripp Leavitt
Tripp Leavitt
MHMichael S. Hu
Michael S. Hu
CMClement D. Marshall
Clement D. Marshall
LBLeandra A. Barnes
Leandra A. Barnes
HLH. Peter Lorenz
H. Peter Lorenz
Michael T. LongakerMichael T. Longaker
Michael T. Longaker